Brief: Positive Results Of Contessa, A Phase 3 Study Of Tesetaxel In Patients With Metastatic Breast Cancer, Presented At The 2020 San Antonio Breast Cancer Symposium (Sabcs)

Odonate

11/12/2020 17:11

Dec 11 (Reuters) - Odonate Therapeutics Inc  ODT.O :
    * POSITIVE RESULTS OF CONTESSA, A PHASE 3 STUDY OF TESETAXEL
IN
PATIENTS WITH METASTATIC BREAST CANCER, PRESENTED AT THE 2020
SAN ANTONIO BREAST CANCER SYMPOSIUM (SABCS)
    * ODONATE THERAPEUTICS INC - PLAN TO SUBMIT A NEW DRUG
APPLICATION
FOR TESETAXEL TO FDA IN MID-2021
    * ODONATE THERAPEUTICS INC - CONTESSA MET PRIMARY ENDPOINT
OF
IMPROVED PFS AS ASSESSED BY IRC

Source text for Eikon:  ID:nBwb6YlJha 
Further company coverage:  ODT.O 

 ((Reuters.Briefs@thomsonreuters.com;))